Factors Involved in the Pharmacokinetics of COL-3, a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer: Clinical and Experimental Studies
- 1 October 2003
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 43 (10) , 1124-1135
- https://doi.org/10.1177/0091270003256675
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit: